TipHub

₹121.8

▲ +5.35 +4.59%

As of 06 Nov 2026 · delayed

NSE Listed

LT-ASM · ASM 1 · T2T
What does LT-ASM · ASM 1 · T2T mean?
NSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-10-27

Maitreya Medicare Limited (MAITREYA)

Volume: 800Avg Vol 1W: 3,520Avg Vol 1M: 6,32052W Range:₹103.1₹292.95
Key Ratios
Checked 8h ago
Market Cap₹83 Cr
Current Price₹121.8
Previous Close₹116.45
High / Low (52w)₹292.95 / ₹103.1
Volume800
Avg Vol (1W)3,520
Avg Vol (1M)6,320
Stock P/E110.71
Book Value₹35.79
Dividend Yield0%
ROE-12.02%
ROA7%
Revenue (TTM)₹46 Cr
Revenue Growth-2.3%
Profit Margin6.29%
Total Debt₹4 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹0
P/B3.4
Debt / Equity0.46
50 DMA₹120.14
200 DMA₹153.86
Day change+4.59%
SurveillanceLT-ASM · ASM 1 · T2T
Price Chart
₹121.8▼ 47.45% · 1Y
₹289₹10831K
2025-11-06
2026-11-06

20-day avg volume: 6K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 85% YoY.
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 111.
Quarterly Results
MetricDec 2022Mar 2023Sept 2023Dec 2023Mar 2024
Revenue₹9 Cr₹11 Cr₹14 Cr₹12 Cr₹12 Cr
EBITDA₹0 Cr₹3 Cr₹3 Cr₹2 Cr₹-1 Cr
Net Profit₹0 Cr₹2 Cr₹2 Cr₹2 Cr₹-1 Cr
EPS—————
Profit & Loss (Annual)
MetricMar 2023Mar 2023Sept 2023Dec 2023Mar 2024Mar 2024Mar 2025Mar 2026
Revenue₹40 Cr₹11 Cr₹14 Cr₹12 Cr₹48 Cr₹11 Cr₹47 Cr₹46 Cr
EBITDA₹7 Cr₹3 Cr₹3 Cr₹2 Cr₹5 Cr₹-1 Cr₹4 Cr₹-1 Cr
Net Profit₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹-1 Cr₹2 Cr₹-2 Cr
EPS6.78———4.15—2.68-3.64
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹14 Cr₹25 Cr₹24 Cr₹29 Cr₹44 Cr₹48 Cr₹68 Cr
Total Liabilities₹10 Cr₹16 Cr₹14 Cr₹13 Cr₹14 Cr₹15 Cr₹39 Cr
Equity₹4 Cr₹10 Cr₹11 Cr₹16 Cr₹30 Cr₹33 Cr₹30 Cr
Total Debt₹8 Cr——————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹6 Cr₹2 Cr₹3 Cr₹-1 Cr₹7 Cr₹8 Cr
Investing₹-5 Cr₹0 Cr₹0 Cr₹-5 Cr₹-7 Cr₹-27 Cr
Financing₹2 Cr₹-2 Cr₹-2 Cr₹12 Cr₹4 Cr₹19 Cr
Free Cash Flow₹6 Cr₹2 Cr₹3 Cr₹-1 Cr₹7 Cr₹8 Cr
Shareholding
Promoter 73.11% Institutions 0% Public 26.89%
Efficiency & Working Capital
ROCE-1.3%
Interest Coverage-0.6
Dividend Payout—
Debtor Days90 d
Inventory Days7 d
Payable Days33 d
Cash Conversion Cycle64 d
Working Capital Days97 d
Shareholding Details

As of 2026-09-30

Promoter73.1%
FII0%
DII0%
Institutions0%
Public26.9%
Promoter Pledge0%
No. of Shareholders1,024
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodAug 2023Aug 2023Oct 2023Oct 2023Nov 2023Nov 2023Mar 2024Sept 2024Mar 2025Sept 2025Mar 2026Sept 2026
Promoters100%100%100%100%73.2%73.2%73.1%73.1%73.1%73.1%73.1%73.1%
FIIs0%0%0%0%1.9%1.9%2.5%0.4%0%0%0%0%
DIIs0%0%0%0%10.3%0%0%0%0%0%0%0%
Public0%0%0%0%14.6%24.9%24.4%26.5%26.9%26.9%26.9%26.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders77775975974749079869789761,024
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Narendra Singh TanwarShareholding of Promoter and Promoter Group47%31,85,808
Pranav Rohitbhai ThakerShareholding of Promoter and Promoter Group15.7%10,61,440
Vimalkumar Natverlal PatelShareholding of Promoter and Promoter Group10.4%7,06,800
South Gujarat Shares And Sharebrokers LimitedPublic Shareholding2.8%1,89,600
Hashim YacoobaliPublic Shareholding1%69,200
Board of Directors
NameDesignationYear
Narendra Singh TanwarChairman & MD & CFO2026
Vimalkumar Natverlal PatelE D & Wholetime Director2026
Hardik PatelIndependent Non Exe. Director2026
Abha SuranaIndependent Non Exe. Director2026
Kashish SuranaCompany Sec. & Compli. Officer2026
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10877
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202616402023
202611100012
2026000203
Company Information
Incorporated2019
ChairmanNarendra Singh Tanwar
AuditorSaherwala & Co
Investor Email[email protected]
🌐 www.maitreyahospitals.com ↗

📍 Nr. Someshwara Char Rasta, UM Road, Surat, Gujarat, 395007

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search